As of 2024-12-12, the Fair Value of ImmunoGen Inc (IMGN) is -1.32 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 31.23 USD, the upside of ImmunoGen Inc is -104.21%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -168.80 | -104.10 | -44.40 | -139.30 | -222.90 | -135.90 |
| YoY growth | -75.83% | 38.33% | 57.35% | -213.74% | -60.01% | -50.78% |
| Market Cap (mil) | 8,724.10 |
| P/E | |
| Forward P/E |
| EPS | -0.26 |
| Avg earnings growth rate | -50.78% |
| TTM earnings | -73.50 |